MASON STREET ADVISORS, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
MASON STREET ADVISORS, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$854,000
+4.1%
8,588
-0.2%
0.01%
-12.5%
Q3 2020$820,000
-16.7%
8,605
-2.2%
0.02%
-20.0%
Q2 2020$984,000
+54.2%
8,795
+0.2%
0.02%
+33.3%
Q1 2020$638,000
-34.5%
8,779
-6.0%
0.02%
-21.1%
Q4 2019$974,000
-1.8%
9,342
-6.3%
0.02%
-9.5%
Q3 2019$992,000
-16.8%
9,970
-4.6%
0.02%
-16.0%
Q2 2019$1,192,000
-12.8%
10,446
-3.9%
0.02%
-10.7%
Q1 2019$1,367,000
-9.5%
10,872
-2.3%
0.03%
-26.3%
Q4 2018$1,511,000
-11.9%
11,133
+78.0%
0.04%
+5.6%
Q3 2018$1,716,000
+34.5%
6,253
+1.6%
0.04%
+24.1%
Q2 2018$1,276,000
+32.0%
6,157
+5.2%
0.03%
+26.1%
Q1 2018$967,000
+28.6%
5,855
+6.7%
0.02%
+35.3%
Q4 2017$752,000
+4.3%
5,489
+3.6%
0.02%
-5.6%
Q3 2017$721,000
+26.5%
5,298
+12.8%
0.02%
+28.6%
Q2 2017$570,000
+21.3%
4,695
+5.8%
0.01%
+16.7%
Q1 2017$470,000
+11.4%
4,438
+6.8%
0.01%
+9.1%
Q4 2016$422,000
+5.8%
4,156
+6.4%
0.01%0.0%
Q3 2016$399,000
-9.7%
3,907
+5.5%
0.01%
-15.4%
Q2 2016$442,000
+28.1%
3,704
+14.9%
0.01%
+18.2%
Q1 2016$345,000
+8.8%
3,223
+10.3%
0.01%
+10.0%
Q4 2015$317,000
+39.0%
2,923
+9.8%
0.01%
+25.0%
Q3 2015$228,000
-8.4%
2,662
+7.7%
0.01%0.0%
Q2 2015$249,000
+36.8%
2,472
+4.5%
0.01%
+33.3%
Q1 2015$182,000
+45.6%
2,366
+0.9%
0.01%
+500.0%
Q4 2014$125,000
+12.6%
2,344
-0.7%
0.00%0.0%
Q3 2014$111,000
-31.5%
2,360
-9.4%
0.00%0.0%
Q2 2014$162,000
-4.1%
2,605
+3.5%
0.00%0.0%
Q1 2014$169,000
-1.2%
2,517
-22.5%
0.00%0.0%
Q4 2013$171,0003,2460.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$8,4593.32%
VILLERE ST DENIS J & CO LLC 480,807$35,368,1622.57%
Chicago Capital, LLC 449,508$33,065,8221.64%
RICE HALL JAMES & ASSOCIATES, LLC 288,345$21,210,6811.20%
Smith, Graham & Co., Investment Advisors, LP 65,163$4,793,3900.58%
Stephens Investment Management Group LLC 455,089$33,476,3470.56%
CARDINAL CAPITAL MANAGEMENT LLC /CT 201,993$14,858,6050.53%
WOODSTOCK CORP 52,604$3,869,5500.49%
Court Place Advisors, LLC 15,533$1,142,6070.41%
Jackson Creek Investment Advisors LLC 12,726$9360.39%
View complete list of LIGAND PHARMACEUTICALS INC shareholders